Medical specialists from Canada tagged as investigators in clinical trials studying Limb-girdle Muscular Dystrophy Type 2A

Total 1 results

Craig Campbell, MD
Seen in:
- Ontario, London, Children's Hospital - London Health Science Centre
- Ontario, London, London Health Sciences Centre
Trials:
- NCT04475926 (Principal Investigator)
- NCT02500381 (Principal Investigator)
Conditions:
- Limb-girdle Muscular Dystrophy;
- Duchenne Muscular Dystrophy

Clinical Trials on Limb-girdle Muscular Dystrophy Type 2A

Linda Pax Lowes

Recruiting

Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E

Limb-Girdle Muscular Dystrophy Type 2A | Limb-Girdle Muscular Dystrophy, Type 2E

United States
Virginia Commonwealth University
University of Colorado, Denver; Washington University School of Medicine; University... and other collaborators

Recruiting

Trial Readiness and Endpoint Assessment in LGMD R1 (GRASP-01-003)

Limb Girdle Muscular Dystrophy | Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A | Limb Girdle Muscular Dystrophy Type R1 | LGMD2A

United States, Netherlands, United Kingdom
IRCCS San Camillo, Venezia, Italy
Universita di Verona; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico and other collaborators

Enrolling by invitation

Clinical and Biochemical Features for the Identification of Dominant Calpainopathies (DOM-CAL)

Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A

Italy
Cooperative International Neuromuscular Research...
Carolinas Medical Center lead study site

Completed

Evaluation of Limb-Girdle Muscular Dystrophy

Becker Muscular Dystrophy | Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency) | Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency) | Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)

United States
The Emmes Company, LLC
Jain Foundation; Coalition to Cure Calpain 3 (C3)

Terminated

Limb-Girdle Video Assessment

Limb-Girdle Muscular Dystrophy ; Subtypes 2A, 2B, and 2I

United States
University Hospital of North Norway
University of Tromso; Norwegian Muscle Disease Association (FFM); Norwegian National... and other collaborators

Active, not recruiting

Limb-Girdle Muscular Dystrophy Type 2I in Norway

Muscular Dystrophies | Limb Girdle Muscular Dystrophy | Limb Girdle Muscular Dystrophy, Type 2I | Limb Girdle Muscular Dystrophy R9 FKRP-related

Norway
ML Bio Solutions, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) (Fortify)

Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)

United States, Netherlands, United Kingdom, Denmark, Australia, Italy, Norway
Nationwide Children's Hospital
Myonexus Therapeutics

Recruiting

Limb Girdle Muscular Dystrophy Type 2E Recruitment Study

Limb-Girdle Muscular Dystrophy, Type 2E

United States
Rigshospitalet, Denmark

Completed

Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I

Becker Muscular Dystrophy | Limb-Girdle Muscular Dystrophy Type 2I

Denmark
Sarepta Therapeutics, Inc.

Active, not recruiting

A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency)

Limb Girdle Muscular Dystrophy

United States

Medical specialists from Canada tagged as investigators in clinical trials studying Limb-girdle Muscular Dystrophy Type 2A

Clinical Trials on Limb-girdle Muscular Dystrophy Type 2A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations